ºÚÁϲ»´òìÈ

Peer-reviewed

2009

1. Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer. M.Tischkowitz, N.Sabbaghian, N.Hamel, A.Borgida, C.Rosner, N.Taherian, A. Srivastava, S. Holter , H.Rothenmund, P.Ghadirian, W.D.Foulkes, S.Gallinger Gastroenterology 2009 Sep;137(3):1183-6. (letter)
2. High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families. Chong G, Jarry J, Marcus V, Thiffault I, Winocour S, Monczak Y, Drouin R, Latreille J, Australie K, Bapat B, Gordon PH, Giguère Y, Gologan A, Galiatsatos P, Jass JR, Wong N, Zaor S, Palma L, Kasprzak L, Tischkowitz M, Foulkes WD. Hum Mutation 2009 30(8):E797-812
3. A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers Pouchet CJ, Wong N, Chong G, Sheehan MJ, Schneider G, Rosen-Sheidley B, Foulkes W, Tischkowitz M. Annals Oncology 2009;20(4):681-8
4. Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases. Novak DJ, Sabbaghian N, Maillet P, Chappuis PO, Foulkes WD, Tischkowitz M. Breast Cancer Res Treat. 2009 Sep;117(2):453-9

2008

1. Spinal Hamartoma with Severe Kyphoscoliosis - A Rare Case of Spinal Mass in a Fetus. Loder D, Lalous M, Rochon L, Albrecht S, Carpineta L, Lefebvre J, Fitzpatrick J, Miner L, Tischkowitz M. Fetal Diagn Ther. 2008;25(1):11-14.
2. Cancer Incidence in Relatives of British Fanconi Anaemia Patients. Tischkowitz M, Easton DF, Ball J, Hodgson SV, Mathew CG. BMC Cancer. 2008 Sep 11;8(1):257.
3. Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases. Novak DJ, Sabbaghian N, Maillet P, Chappuis PO, Foulkes WD, Tischkowitz M. Breast Cancer Res Treat. 2008 [Epub ahead of print]
4. Large Genomic Deletions of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene in Pituitary Adenoma Predisposition. Georgitsi M, Heliövaara E, Paschke R, Kumar AV, Tischkowitz M, Vierimaa O, Salmela P, Sane T, De Menis E, Cannavò S, Gündogdu S, Lucassen A, Izatt L, Aylwin S, Bano G, Hodgson S, Koch CA, Karhu A, Aaltonen LA. J Clin Endocrinol Metab. 2008 93(10):4146-51
5. Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. Tischkowitz MD, Yilmaz A, Chen LQ, Karyadi DM, Novak D, Kirchhoff T, Hamel N, Tavtigian SV, Kolb S, Bismar TA, Aloyz R, Nelson PS, Hood L, Narod SA, White KA, Ostrander EA, Isaacs WB, Offit K, Cooney KA, Stanford JL, Foulkes WD. Cancer Lett. 2008 Jun 19. [Epub ahead of print]
6. Pathogenicity of a BRCA1 missense variant is determined by the disruption of the phosphopeptide binding pocket – a multi-modal approach. M. Tischkowitz, N. Hamel1, M. A. Carvalho, G. Birrane, A. Soni, E. H. van Beers, S.A. Joosse, N. Wong, D. Novak, L.A. Quenneville, S. Grist, kConFab, P.M. Nederlof, D.E. Goldgar, S.V. Tavtigian, A. N.A. Monteiro, J.A.A. Ladias, W.D. Foulkes. European Journal of Human Genetics 2008 16(7):820-32.
7. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. Marc Tischkowitz, Nelly Sabbaghian, Anna M. Ray, William D Foulkes, Kathleen A. Cooney. The Prostate. 2008 1;68(6):675-8.